Modular Medical, Inc.

NasdaqCM:MODD Stock Report

Market Cap: US$17.9m

Modular Medical Past Earnings Performance

Past criteria checks 0/6

Modular Medical's earnings have been declining at an average annual rate of -14.6%, while the Medical Equipment industry saw earnings growing at 18.2% annually.

Key information

-14.62%

Earnings growth rate

37.75%

EPS growth rate

Medical Equipment Industry Growth8.90%
Revenue growth raten/a
Return on equity-260.37%
Net Marginn/a
Last Earnings Update30 Jun 2026

Recent past performance updates

No updates

Recent updates

Analysis Article • Jul 16

Here's Why Modular Medical (NASDAQ:MODD) Must Use Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Analysis Article • Oct 08

Here's Why We're A Bit Worried About Modular Medical's (NASDAQ:MODD) Cash Burn Situation

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Analysis Article • Mar 15

Modular Medical (NASDAQ:MODD) Will Have To Spend Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Analysis Article • Nov 19

We're Keeping An Eye On Modular Medical's (NASDAQ:MODD) Cash Burn Rate

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Seeking Alpha • Jul 26

Modular Medical appoints Kevin Schmid as COO

Modular Medical (NASDAQ:MODD) has appointed industry veteran Kevin Schmid as its Chief Operating Officer. Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturing. He was most recently the CEO of Common Sensing.
Analysis Article • Jul 22

We Think Modular Medical (NASDAQ:MODD) Needs To Drive Business Growth Carefully

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Seeking Alpha • Mar 21

Modular Medical: Next Generation Insulin Pump Developer

Modular Medical develops insulin pumps for diabetes management. The Company plans to submit its MODD1 device for FDA marketing approval in Q2 and launch by year-end. The Company is targeting a $3 billion market with an unmet need in insulin injection therapy.

Revenue & Expenses Breakdown

How Modular Medical makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NasdaqCM:MODD Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 260-28819
31 Mar 260-28820
31 Dec 250-27720
30 Sep 250-24619
30 Jun 250-21517
31 Mar 250-19415
31 Dec 240-18514
30 Sep 240-19514
30 Jun 240-18513
31 Mar 240-17513
31 Dec 230-17512
30 Sep 230-15410
30 Jun 230-14510
31 Mar 230-1459
31 Dec 220-1569
30 Sep 220-1668
30 Jun 220-1778
31 Mar 220-1978
31 Dec 210-1667
30 Sep 210-1356
30 Jun 210-1045
31 Mar 210-734
31 Dec 200-834
30 Sep 200-734
30 Jun 200-633
31 Mar 200-523
31 Dec 190-423
30 Sep 190-413
30 Jun 190-312
31 Mar 190-312
31 Dec 180-211
30 Sep 180-111
30 Jun 180-100
31 Mar 180-100
31 Dec 170000
30 Sep 170000
30 Jun 170000
31 Mar 170000
31 Dec 160000
30 Sep 160000
30 Jun 160000
31 Mar 160000
31 Dec 150000

Quality Earnings: MODD is currently unprofitable.

Growing Profit Margin: MODD is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: MODD is unprofitable, and losses have increased over the past 5 years at a rate of 14.6% per year.

Accelerating Growth: Unable to compare MODD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MODD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (21.3%).

Return on Equity

High ROE: MODD has a negative Return on Equity (-260.37%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/20 14:48
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Modular Medical, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Steven LichtmanOppenheimer & Co. Inc.
Bruce JacksonStoneX Financial, Inc.